Overview

Imaging Histone Deacetylase in the Heart

Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The overall goal of this PET-MR imaging trial is to evaluate 11C-Martinostat, a histone deacetylase targeted radioligand, in patients with aortic stenosis, individuals with diabetes, and healthy volunteers.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital